Pacific Biosciences of California Inc (NASDAQ: PACB) kicked off on Friday, up 2.53% from the previous trading day, before settling in for the closing price of $1.98. Over the past 52 weeks, PACB has traded in a range of $1.16-$10.65.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 24.48% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded -12.49%. With a float of $262.20 million, this company’s outstanding shares have now reached $273.81 million.
In an organization with 796 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 18.12%, operating margin of -215.33%, and the pretax margin is -228.11%.
Pacific Biosciences of California Inc (PACB) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Pacific Biosciences of California Inc is 4.26%, while institutional ownership is 81.68%. The most recent insider transaction that took place on Sep 30 ’24, was worth 34,065. In this transaction an insider of this company sold 19,782 shares at a rate of $1.72, taking the stock ownership to the 695,654 shares. Before that another transaction happened on Sep 30 ’24, when Company’s Officer proposed sale 19,782 for $1.72, making the entire transaction worth $34,061.
Pacific Biosciences of California Inc (PACB) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around -12.49% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -1.00% during the next five years compared to -9.76% drop over the previous five years of trading.
Pacific Biosciences of California Inc (NASDAQ: PACB) Trading Performance Indicators
Take a look at Pacific Biosciences of California Inc’s (PACB) current performance indicators. Last quarter, stock had a quick ratio of 8.64. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.29.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.46, a number that is poised to hit -0.20 in the next quarter and is forecasted to reach -0.68 in one year’s time.
Technical Analysis of Pacific Biosciences of California Inc (PACB)
Let’s dig in a bit further. During the last 5-days, its volume was 10.8 million. That was better than the volume of 9.65 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 74.35%. Additionally, its Average True Range was 0.21.
During the past 100 days, Pacific Biosciences of California Inc’s (PACB) raw stochastic average was set at 52.41%, which indicates a significant decrease from 83.08% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 81.25% in the past 14 days, which was lower than the 112.38% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.93, while its 200-day Moving Average is $2.17. However, in the short run, Pacific Biosciences of California Inc’s stock first resistance to watch stands at $2.11. Second resistance stands at $2.19. The third major resistance level sits at $2.25. If the price goes on to break the first support level at $1.97, it is likely to go to the next support level at $1.91. Assuming the price breaks the second support level, the third support level stands at $1.83.
Pacific Biosciences of California Inc (NASDAQ: PACB) Key Stats
The company with the Market Capitalisation of 569.98 million has total of 273,864K Shares Outstanding. Its annual sales at the moment are 200,520 K in contrast with the sum of -306,740 K annual income. Company’s last quarter sales were recorded 39,970 K and last quarter income was -60,730 K.
